BRAF and melanoma: In a melanoma with BRAF mutation, slow‐cycling persister cells display an increased level of mitochondrial oxidative‐ATP‐synthetic gene expression after treatment as well as improve their susceptibility to mitochondrial respiratory chain inhibition.70, 191